Cagrilintide/semaglutide
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Novo Nordisk · Phase 3 · Recruiting · Enrollment 2500
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cagrisema - dose level 1 | Obesity + T2D | n/r | 83 | n/r | n/r |
| Cagrisema - dose level 2 | Obesity + T2D | n/r | 83 | n/r | n/r |
| Semaglutide | Obesity + T2D | n/r | 83 | n/r | n/r |